Skip to content

CRP study: The value of C-reactive protein (CRP) testing in acutely ill children

A pilot study on the effects of adding C-reactive protein point-of-care testing in the management of acutely ill children in primary care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN69736109
Enrollment
700
Registered
2013-07-22
Start date
2013-07-08
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Primary Care Research Network for England

Interventions

Patients that consent and are eligible will be randomised between the intervention arm and standard care. CRP Test, Patients will receive a finger prick in order to obtain a blood sample for a C-Reac

Sponsors

University of Oxford (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Participant/parent or guardian is willing and able to give informed consent for participation in the study. 2. Male or Female, aged 1 month to 16 years. 3. Presenting to out-of-hours with an acute illness of a maximum of 5 days. 4. A subset of children, i.e. Those with a body temperature >=38°C, will be randomised to CRP or no CRP testing.

Exclusion criteria

Exclusion criteria: 1. Acute trauma 2. Clinically unstable warranting immediate care 3. Prior inclusion in the study 4. Prior inclusion in another clinical trial of an investigational medicinal product in the last 90 days or any other research in the last 30 days

Design outcomes

Primary

MeasureTime frame
Recruitment Rate; Timepoints: Recruitment rate of children to the study over the length of the trial, approximately 6 months.

Secondary

MeasureTime frame
1. Difference in antibiotic prescription rates. 2. Difference in referrals. 3. Difference in additional testing rates. 4. Difference in hospital admission. 5. Acceptability of the blood test by children and their parents/guardians. 6. Feasibility of the blood test by a nurse. 7. Impact of the blood test on the GPs diagnostic certainty. 8. Impact of the vital signs measurements applied on percentiles and prediction score on GPs diagnostic certainty.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026